4.7 Article

P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer Statistics, 2012

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2012)

Review Immunology

Potential targets for pancreatic cancer immunotherapeutics

Lindzy F. Dodson et al.

IMMUNOTHERAPY (2011)

Review Multidisciplinary Sciences

Cancer immunotherapy comes of age

Ira Mellman et al.

NATURE (2011)

Review Biochemistry & Molecular Biology

Immunity, Inflammation, and Cancer

Sergei I. Grivennikov et al.

Review Medicine, General & Internal

Pancreatic Cancer

Manuel Hidalgo

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.

Philip W. Kantoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Oncology

Potential target antigens for immunotherapy in human pancreatic cancer

F. H. Schmitz-Winnenthal et al.

CANCER LETTERS (2007)

Article Biochemical Research Methods

In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire

WY Ho et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2006)

Review Oncology

A listing of human tumor antigens recognized by T cells: March 2004 update

L Novellino et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)